ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total current assets

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥455.2B
P/E ratio
43.4x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Dec 31, 2025148,820+3.01%
Dec 31, 2024144,468-8.76%
Dec 31, 2023158,331-8.42%
Dec 31, 2022172,892-4.95%
Dec 31, 2021181,889+10.76%
Dec 31, 2020164,225+0.93%
Dec 31, 2019162,712+4.94%
Dec 31, 2018155,058+8.93%
Dec 31, 2017142,346+10.65%
Dec 31, 2016128,646+6.90%
Mar 31, 2016120,347+3.76%
Mar 31, 2015115,990

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat